The review says Wegovy offers value for money and should be offered to certain public patients, even though the budget impact would be high.
Recap by typeshit. Post by Facebook on Facebook.
The GLP-1 Bridge pilot runs through 2027 and covers approved pills and shots for eligible Part D and Advantage enrollees, with no deductible.
Le Figaro reports the tablet arrives in early November. Unlike the Wegovy injection, it won't be covered by France's public reimbursement system.
A TV segment airing on WSIL and KFVS looks at the weight loss drug trend and what coverage people might be able to get through their insurance today.
Monthly units climbed from 114,000 in February to 434,000 in September, and sales value rose from ₹48 cr to ₹113 cr as doctors report wider access.
An Audacy listing page gathering coverage on BPC-157 and peptides alongside Kennedy and Trump, with no story details given.
An August 2025 ruling sided with Novo Nordisk and Lilly. Plaintiffs need an accepted test, not just symptoms or records, and testing after stopping the drug can complicate a claim.
Loading…